The U.S. Food and Drug Administration (FDA) has approved Ferring Pharmaceuticals Inc.’s Zomacton (somatropin) for injection in four additional pediatric indications: Idiopathic short stature (ISS) Short stature associated with Turner syndrome Short stature born small for gestational age (SGA) with no catch-up growth by 2 to 4 years Short stature or growth failure in short stature…